Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer. Janux Therapeutics Inc is an innovative biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to better treat patients suffering from cancer.
Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technology to its...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 3.02 | 7.34972012655 | 41.09 | 44.16 | 39.33 | 1107780 | 40.51330011 | CS |
4 | -11.04 | -20.0181323663 | 55.15 | 61.59 | 39.33 | 1127803 | 48.59415716 | CS |
12 | -10.465 | -19.1754466331 | 54.575 | 71.71 | 39.33 | 1153539 | 54.69953226 | CS |
26 | -0.4 | -0.898674455179 | 44.51 | 71.71 | 34.5125 | 826614 | 51.23651226 | CS |
52 | 34.3 | 349.643221203 | 9.81 | 71.71 | 7.79 | 842705 | 48.40725767 | CS |
156 | 30.13 | 215.522174535 | 13.98 | 71.71 | 5.65 | 344041 | 41.83178829 | CS |
260 | 10.11 | 29.7352941176 | 34 | 71.71 | 5.65 | 316265 | 40.15341947 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約